ALBIREO PHARMA INC (ALBO) Forecast, Price Target & Analyst Ratings

NASDAQ:ALBO • US01345P1066

Current stock price

44.15 USD
-0.1 (-0.23%)
At close:
44.33 USD
+0.18 (+0.41%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALBIREO PHARMA INC (ALBO).

Forecast Snapshot

Consensus Price Target

Price Target
$42.84
-2.97% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 15, 2023
Period
Q4 / 2022
EPS Estimate
-$2.01
Revenue Estimate
10.038M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
76.92%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$42.84
Upside
-2.97%
From current price of $44.15 to mean target of $42.84, Based on 13 analyst forecasts
Low
$42.42
Median
$42.84
High
$44.10

Price Target Revisions

1 Month
-4.11%
3 Months
-28.41%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for ALBO. The average price target is 42.84 USD. This implies a price decrease of -2.97% is expected in the next year compared to the current price of 44.15.
The average price target has been revised downward by 28.41% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ALBO Current Analyst RatingALBO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

ALBO Historical Analyst RatingsALBO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
76.92%
ALBO was analyzed by 13 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about ALBO.
In the previous month the buy percentage consensus was at a similar level.
ALBO was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-02-15HC Wainwright & Co.Reiterate Neutral
2023-01-11GuggenheimDowngrade Buy -> Neutral
2023-01-11Cowen & Co.Downgrade Outperform -> Market Perform
2023-01-11JefferiesDowngrade Buy -> Hold
2023-01-10HC Wainwright & Co.Downgrade Buy -> Neutral
2023-01-09WedbushDowngrade Outperform -> Neutral
2022-10-13HC Wainwright & Co.Maintains Buy
2022-10-12BairdMaintains Outperform
2022-09-08GuggenheimInitiate Buy
2022-08-16WedbushMaintains Outperform
2022-08-16BairdMaintains Outperform
2022-08-16HC Wainwright & Co.Maintains Buy
2022-05-17BairdMaintains Outperform
2021-11-05HC Wainwright & Co.Maintains Buy
2021-09-16WedbushMaintains Outperform
2021-07-21WedbushMaintains Outperform
2021-07-21HC Wainwright & Co.Maintains Buy
2021-03-01Piper SandlerMaintains Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 15, 2023
Period
Q4 / 2022
EPS Estimate
-$2.01
Revenue Estimate
10.038M
Revenue Q2Q
-69.13%
EPS Q2Q
-252.53%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
-0.45%
Revenue (3 Months)
-0.40%
EPS (1 Month)
-7.40%
EPS (3 Months)
-7.40%

Next Earnings Summary

ALBO is expected to report earnings on 5/15/2023. The consensus EPS estimate for the next earnings is -2.01 USD and the consensus revenue estimate is 10.04M USD.
The next earnings revenue estimate has been revised downward by 0.4% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
ALBO revenue by date.ALBO revenue by date.
9.64M
-24.33%		8.31M
-13.80%		40.579M
388.32%		35.072M
-13.57%		61.913M
76.53%		148.29M
139.51%		247.64M
67.00%		437.82M
76.80%		636.96M
45.48%		747.61M
17.37%		873.18M
16.80%		993.53M
13.78%
EBITDA
YoY % growth
ALBO ebitda by date.ALBO ebitda by date.
-60.98M
-61.15%		-96.08M
-57.56%		-123.211M
-28.24%		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ALBO ebit by date.ALBO ebit by date.
-61.11M
-61.28%		-96.27M
-57.54%		-123.485M
-28.27%		-154.126M
-24.81%		-136.578M
11.39%		-65.993M
51.68%		5.59M
108.47%		167.17M
2,890.52%		327.31M
95.79%		372.01M
13.66%		462.1M
24.22%		547.88M
18.56%
Operating Margin
ALBO operating margin by date.ALBO operating margin by date.
-633.92%-1,158.48%-304.31%-439.46%-220.60%-44.50%2.26%38.18%51.39%49.76%52.92%55.14%
EPS
YoY % growth
ALBO eps by date.ALBO eps by date.
-5.35
-37.89%		-6.87
-28.41%		-6.78
1.31%		-8.20
-20.91%		-6.71
18.08%		-3.76
43.95%		0.61
116.08%		6.45
965.78%		12.91
100.13%		11.04
-14.50%		11.22
1.66%		10.70
-4.64%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25
EPS
Q2Q % growth		-2.01
-252.53%		-1.69
22.68%		-1.75
14.00%		-1.71
11.02%		-1.61
19.71%		-1.13
33.43%		-1.33
24.13%		-1.19
30.15%		-1.06
34.56%		-1.77
-57.47%		-1.83
-37.16%		-1.90
-58.97%
Revenue
Q2Q % growth		10.038M
-69.13%		11.82M
73.01%		13.128M
59.98%		14.708M
49.59%		18.509M
84.39%		18.462M
56.19%		18.564M
41.41%		18.768M
27.60%		19.074M
3.05%		22.032M
19.34%		22.134M
19.23%		22.236M
18.48%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-40.301M
-250.63%		-35.685M
9.79%		-34.324M
7.74%		-34.206M
1.30%		-31.172M
22.65%		N/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ALBO Yearly Revenue VS EstimatesALBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
ALBO Yearly EPS VS EstimatesALBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
13.05%
EPS Next 5 Year
24.17%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
92.77%
Revenue Next 5 Year
84.10%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ALBIREO PHARMA INC / ALBO Forecast FAQ

What is the average price target for ALBIREO PHARMA INC (ALBO) stock?

13 analysts have analysed ALBO and the average price target is 42.84 USD. This implies a price decrease of -2.97% is expected in the next year compared to the current price of 44.15.

Can you provide the upcoming earnings date for ALBIREO PHARMA INC?

ALBIREO PHARMA INC (ALBO) will report earnings on 2023-05-15.

What are the consensus estimates for ALBO stock next earnings?

The consensus EPS estimate for the next earnings of ALBIREO PHARMA INC (ALBO) is -2.01 USD and the consensus revenue estimate is 10.04M USD.

What is the consensus rating for ALBO stock?

The consensus rating for ALBIREO PHARMA INC (ALBO) is 76.9231 / 100 . This indicates that analysts generally have a positive outlook on the stock.